NWS
62
4
D
41
4
HIG
54
2
PNC
55
3
KR
44
4
RL
72
3
BLK
69
3
PGR
58
6
JBHT
63
3
AKAM
54
3
THC
67
2
BEN
34
6
EXPD
40
3
SYY
45
2
HAS
37
4
SJM
19
5
HRB
56
2
AVGO
32
7
GIS
29
3
STZ
47
-3
NWS
62
4
D
41
4
HIG
54
2
PNC
55
3
KR
44
4
RL
72
3
BLK
69
3
PGR
58
6
JBHT
63
3
AKAM
54
3
THC
67
2
BEN
34
6
EXPD
40
3
SYY
45
2
HAS
37
4
SJM
19
5
HRB
56
2
AVGO
32
7
GIS
29
3
STZ
47
-3
Financhill
Back

Novo Nordisk AS Vs. Genmab AS Industry Stock Comparison

Sell
27

NONOF
Novo Nordisk AS

Last Price:
106.21
Seasonality Move:
9.66%
Sell
29

GMAB
Genmab AS

Last Price:
22.76
Seasonality Move:
4.61%
Sell
27
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $106.21. The Score for NONOF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy, Sell or Hold?

  • The current Genmab AS [GMAB] share price is $22.75. The Score for GMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $106.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.

GMAB Stock Price Chart

What is Genmab AS's stock price today?

  • The Genmab AS share price today is $22.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.9 Sell
Relative Strength Index (14 RSI): 33.44 Sell
Chaikin Money Flow: -23361 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.38 - 119.06) Sell
Bollinger Bands (100): (119.42 - 140.4) Sell

GMAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 38.46 Sell
Chaikin Money Flow: 1189998 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.68 - 23.5) Sell
Bollinger Bands (100): (23.86 - 27.54) Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.81 Sell
20-day SMA: 114.93 Sell
50-day SMA: 123.26 Sell
200-day SMA: 128.08 Sell
8-day EMA: 110.63 Sell
20-day EMA: 114.37 Sell
50-day EMA: 120.7 Sell
200-day EMA: 122.52 Sell

GMAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.79 Sell
20-day SMA: 22.99 Sell
50-day SMA: 24.68 Sell
200-day SMA: 27.29 Sell
8-day EMA: 22.75 Sell
20-day EMA: 23.1 Sell
50-day EMA: 24.24 Sell
200-day EMA: 27.4 Sell

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Genmab AS Earnings Growth & GMAB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.33 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Genmab AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):